AVBP — ARRIVENT BIOPHARMA INC COM

Ownership history in Parallel Advisors, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Parallel Advisors, LLC reported a position in ARRIVENT BIOPHARMA INC COM (AVBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 82 — 0% 0.00% $2K $18.45
2025 Q2 ADDED 82 +79 +2633.3% 0.00% $2K $21.77
2024 Q4 INITIATED 3 — — 0.00% $80 $26.64
% of Fund (quarterly)    AVBP price (monthly, adj. close)

Other funds also holding AVBP

As of 2025 Q4 — sorted by position size

General Catalyst Group Management, LLC 3Y 7Y 13.56% AIHC Capital Management Ltd 12.16% Octagon Capital Advisors LP 3Y 4.81% Novo Holdings A/S 3Y 7Y 3.03% HHLR ADVISORS, LTD. 3Y 7Y 2.55% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.69% Rosalind Advisors, Inc. 1.53% Sofinnova Investments, Inc. 3Y 7Y 1.47% Fund 1 Investments, LLC 3Y 1.39% ORBIMED ADVISORS LLC 3Y 7Y 1.24%
← Back to Parallel Advisors, LLC Holdings